Fact CheckerSign in

NCT06476184RecruitingPhase 3

Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

A Pragmatic Randomized Phase III Trial to Assess the Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

SALVOVAR will be a pragmatic open-label multicenter randomized phase III trial (ratio 1:1) comparing the efficacy of the salvage weekly dose-dense regimen with those of the continuation of the standard regimen.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
250 (estimated)
First submitted
5 Jun 2024
Start date
30 Jul 2024
Primary completion date
Jun 2027
Lead sponsor
ARCAGY/ GINECO GROUP
NCT number
NCT06476184

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 250
  • From 30 Jul 2024 to the primary completion date, Jun 2027
  • 76 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Histologically confirmed high-grade epithelial (serous, endometrioid, or carcinosarcoma with a ≥30% epithelial tumor component) ovarian, primary peritoneal, or fallopian-tube carcinoma
  • Adult patient aged ≥ 18 years old
  • Advanced stage III or IV disease
  • Treated with 3 to 4 neo-adjuvant cycles of standard 3-weekly carboplatin-paclitaxel regimen in first-line setting, and characterized by:
    • Unfavorable standardized KELIMTM score \< 1.0 calculated with the KELIMTM academic tool and available for free on internet site (https://www.biomarker-kinetics.org/CA-125-neo) (poor primary chemosensitivity)
    • Not amenable to complete interval debulking surgery (incomplete interval debulking surgery attempt, or disease not operated at all because considered not amenable to complete surgery by surgeon) Of note, a pre-screening inclusion before the start of neo-adjuvant chemotherapy is encouraged as a way of prospectively assessing the CA-125 longitudinal kinetics and surgery evaluation, and subsequently selecting the patients for the randomization sequence
  • ECOG performance status 0 or 1 (see appendix 2)
  • Adequate organ and bone marrow function for weekly-dense chemotherapy: red blood cells (baseline Hemoglobin ≥8 g/dL without red blood cell transfusion within 3 weeks before the blood work), white blood cells (Absolute neutrophil count (ANC) ≥1500 cells/mm3) and platelets (Platelet count ≥100,000/mm3),
  • Adequate renal and liver functions
    • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤2.5 × upper limit of normal (ULN), or ≤5 × ULN in context of liver metastases
    • Total bilirubin ≤1.5 × ULN (patients with Gilbert's are eligible if total bilirubin ≤3 × ULN)
    • Albumin ≥3 g/dL
    • Creatinine clearance ≥40 mL/min/1.73 m2 (measured or estimated, ideally with CKD-EPI formula on https://www.kidney.org/professionals/kdoqi/gfr\_calculator)
  • Patients who gave its written informed consent to participate to the study
  • Patients affiliated to a social insurance regime
  • Patients willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
    • Non-inclusion Criteria:
  • Low-grade endometrioid, clear cell, mucinous, or sarcomatous histology, or mixed tumors containing any of these histologies, or low-grade or borderline ovarian tumor. Contraindication to the drugs assessed in the SALVOVAR trial (carboplatin, paclitaxel, GCSF)
  • Previous treatment with bevacizumab during initial standard neo-adjuvant chemotherapy
  • Has primary platinum-refractory disease, defined as disease that has progressed during the neo-adjuvant chemotherapy
  • Patients with concomitant cancer, except: adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumors curatively treated with no evidence of disease for ≥ 5 years
  • Treatment with other investigational agents in clinical trials during the randomized chemotherapy phase for both arms.
  • Clinically significant uncontrolled condition(s) which, in the opinion of the Investigator, may confound the results of the trial or interfere with the patient's safety or participation, including but not limited to:
    • Unstable angina.
    • Myocardial infarction within 6 months of first dose.
    • Uncontrolled and/or severe concomitant diseases (uncontrolled hypertension, ≥ Grade 3 (per CTCAE v5.0) arrhythmia, heart failure, cirrhosis).
    • Active infectious disease requiring IV therapy (bacteria, viruses) within 2 weeks of first dose.
    • Gastric-outlet obstruction.
    • Small bowel obstruction (SBO) defined as computed tomography (CT) scan showing: Dilated loops of small bowel ≤12 weeks of study entry, symptomatic ascites/effusions requiring paracentesis or thoracentesis ≤30 days of study entry.
  • Known psychiatric disorder that would interfere with trial compliance.
  • Pregnant or lactating patients or patients expecting to conceive children within the projected duration of the trial.
  • Patient deprived of liberty, under guardianship, or under curatorship.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (76)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
ICO Paul Papin
Coordinator of this site? Confirm its status
AngersFranceRecruiting
Sainte Catherine Institut du Cancer Avignon Provence
Coordinator of this site? Confirm its status
AvignonFranceRecruiting
CH d'Avignon
Coordinator of this site? Confirm its status
AvignonFranceRecruiting
Hopital de la cote Basque
Coordinator of this site? Confirm its status
BayonneFranceRecruiting
CHRU Besançon - Hôpital Jean Minjoz
Coordinator of this site? Confirm its status
BesançonFranceRecruiting
Institut Bergonie
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting
Chu de Brest - Hôpital Cavale Blanche
Coordinator of this site? Confirm its status
BrestFranceRecruiting
Centre François Baclesse
Coordinator of this site? Confirm its status
CaenFranceRecruiting
Centre d'Oncologie et de Radiothérapie 37 (ROC37)
Coordinator of this site? Confirm its status
Chambray-lès-ToursFranceRecruiting
Centre Hospitalier de Cholet
Coordinator of this site? Confirm its status
CholetFranceRecruiting
Centre Jean Perrin
Coordinator of this site? Confirm its status
Clermont-FerrandFranceRecruiting
Centre Hospitalier Alpes Leman
Coordinator of this site? Confirm its status
Contamine-sur-ArveFranceNot yet recruiting
Centre Hospitalier Intercommunal de Créteil
Coordinator of this site? Confirm its status
CréteilFranceRecruiting
Centre Georges François Leclerc
Coordinator of this site? Confirm its status
DijonFranceRecruiting
CHU de DIJON
Coordinator of this site? Confirm its status
DijonFranceRecruiting
Groupe Hospitalier Mutualiste de Grenoble
Coordinator of this site? Confirm its status
GrenobleFranceRecruiting
Hôpital André Mignot
Coordinator of this site? Confirm its status
Le ChesnayFranceRecruiting
CHRU de Lille
Coordinator of this site? Confirm its status
LilleFranceNot yet recruiting
Centre Oscar Lambret
Coordinator of this site? Confirm its status
LilleFranceRecruiting
CHU de Limoges-Hopital Dupuytren
Coordinator of this site? Confirm its status
LimogesFranceRecruiting
Centre Leon Berard
Coordinator of this site? Confirm its status
LyonFranceRecruiting
Hôpital Privé Jean Mermoz
Coordinator of this site? Confirm its status
LyonFranceRecruiting
Hôpital de la Croix Rousse
Coordinator of this site? Confirm its status
LyonFranceNot yet recruiting
Hopital de la Timone
Coordinator of this site? Confirm its status
MarseilleFranceNot yet recruiting
ICM Val d'Aurelle
Coordinator of this site? Confirm its status
MontpellierFranceRecruiting
CHRU de Montpellier - Hôpital Saint-Eloi
Coordinator of this site? Confirm its status
MontpellierFranceRecruiting
Centre Azuréen de Cancérologie
Coordinator of this site? Confirm its status
MouginsFranceRecruiting
Hôpital Privé du Confluent
Coordinator of this site? Confirm its status
NantesFranceRecruiting
Centre Antoine Lacassagne
Coordinator of this site? Confirm its status
NiceFranceRecruiting
Institut de Cancérologie du Gard - CHU de Nîmes
Coordinator of this site? Confirm its status
NîmesFranceRecruiting
Hopital Européen George Pompidou
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Hôpital Cochin
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Institut Curie
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Groupe Hospitalier Diaconesses Croix Saint-Simon
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Centre Hospitalier General de Pau
Coordinator of this site? Confirm its status
PauFranceRecruiting
HCL Centre Hospitalier Lyon Sud
Coordinator of this site? Confirm its status
Pierre-BéniteFranceRecruiting
Hôpital de Poissy-Saint-Germain-en-Laye
Coordinator of this site? Confirm its status
PoissyFranceNot yet recruiting
Institut Jean Godinot
Coordinator of this site? Confirm its status
ReimsFranceRecruiting
Centre Eugène Marquis
Coordinator of this site? Confirm its status
RennesFranceRecruiting
Hôpital privé de la Loire
Coordinator of this site? Confirm its status
Saint-EtienneFranceNot yet recruiting
Institut de Cancérologie de l'Ouest (ICO)
Coordinator of this site? Confirm its status
Saint-HerblainFranceRecruiting
CHU Saint-Etienne - Pôle de Cancérologie
Coordinator of this site? Confirm its status
Saint-Priest-en-JarezFranceRecruiting
ICANS - Institut de cancérologie Strasbourg Europe
Coordinator of this site? Confirm its status
StrasbourgFranceRecruiting
CHU Strasbourg - Hôpital de Hautepierre
Coordinator of this site? Confirm its status
StrasbourgFranceRecruiting
Hopital Foch
Coordinator of this site? Confirm its status
SuresnesFranceRecruiting
Hôpitaux du Léman - site Thonon-les-Bains
Coordinator of this site? Confirm its status
Thonon-les-BainsFranceNot yet recruiting
Oncopole Claudius Regaud IUCT ONCOPOLE
Coordinator of this site? Confirm its status
ToulouseFranceRecruiting
Clinique Pasteur
Coordinator of this site? Confirm its status
ToulouseFranceRecruiting
Centre Hospitalier de Valence
Coordinator of this site? Confirm its status
ValenceFranceRecruiting
Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceRecruiting
Azienda Ospedaliero-Universitaria Ss.Antonio E Biagio E C.Arrigo Alessandria
Coordinator of this site? Confirm its status
AlessandriaItalyNot yet recruiting
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Coordinator of this site? Confirm its status
BolognaItalyRecruiting
Careggi University Hospital
Coordinator of this site? Confirm its status
FlorenceItalyNot yet recruiting
Alessandro Manzoni Hospital
Coordinator of this site? Confirm its status
LeccoItalyNot yet recruiting
Istituto Europeo di Oncologia s.r.l
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Azienda Ulss 3 Serenissima
Coordinator of this site? Confirm its status
VeniceItalyNot yet recruiting
The University of Tokyo Hospital
Coordinator of this site? Confirm its status
Bunkyō CityJapanNot yet recruiting
Fukushima Medical University Hospital
Coordinator of this site? Confirm its status
FukushimaJapanRecruiting
Saitama Medical University International Medical Center
Coordinator of this site? Confirm its status
HidakaJapanRecruiting
Hirosaki University Hospital
Coordinator of this site? Confirm its status
HirosakiJapanNot yet recruiting
The Jikei University Kashiwa Hospital
Coordinator of this site? Confirm its status
KashiwaJapanRecruiting
St. Marianna University Hospital
Coordinator of this site? Confirm its status
KawasakiJapanRecruiting
Dokkyo Medical University Saitama Medical Center
Coordinator of this site? Confirm its status
KoshigayaJapanNot yet recruiting
Kurume University Hospital
Coordinator of this site? Confirm its status
KurumeJapanNot yet recruiting
Nagoya University Hospital
Coordinator of this site? Confirm its status
NagoyaJapanRecruiting
Kindai University Hospital
Coordinator of this site? Confirm its status
SayamaJapanRecruiting
Tohoku University Hospital
Coordinator of this site? Confirm its status
SendaiJapanRecruiting
Osaka Medical and Pharmaceutical University Hospital
Coordinator of this site? Confirm its status
TakatsukiJapanNot yet recruiting
The Jikei University Daisan Hospital
Coordinator of this site? Confirm its status
TokyoJapanNot yet recruiting
The Cancer Institute Hospital of JFCR
Coordinator of this site? Confirm its status
TokyoJapanNot yet recruiting
The Jikei University Katsushika Medical Center
Coordinator of this site? Confirm its status
TokyoJapanNot yet recruiting
The Jikei University Hospital
Coordinator of this site? Confirm its status
TokyoJapanRecruiting
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Coordinator of this site? Confirm its status
AmsterdamNetherlandsNot yet recruiting
Leids Universitair Medisch Centrum (LUMC)
Coordinator of this site? Confirm its status
LeidenNetherlandsNot yet recruiting
Radboud University Medical Center
Coordinator of this site? Confirm its status
NijmegenNetherlandsNot yet recruiting
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Coordinator of this site? Confirm its status
RotterdamNetherlandsNot yet recruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.